Related Experiment Video
Updated: Jun 23, 2026
04:30
A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
Published on: May 14, 2013
Life after coronary stent thrombosis
David Becker1, Pal Maurovich-Horvat, György Barczi
1Semmelweis University Heart Center Budapest, Budapest, Hungary.
Summary
Outcomes for patients experiencing stent thrombosis (ST) are poor, with higher rates of major cardiovascular events and repeat revascularization compared to de novo myocardial infarction. Further research is needed to improve ST management.
Area of Science:
- Cardiology
- Interventional Cardiology
Background:
- Coronary stent thrombosis is a severe complication of percutaneous coronary intervention.
- Limited long-term data exists on the clinical outcomes of patients who have experienced stent thrombosis.
Purpose of the Study:
- To evaluate the long-term clinical outcomes of patients with ST-segment elevation myocardial infarction (STEMI), comparing those with de novo STEMI to those with STEMI caused by stent thrombosis.
Main Methods:
- A retrospective study of 1890 consecutive STEMI patients from January 2003 to December 2005.
- Compared outcomes between 1843 patients with de novo STEMI and 47 patients with STEMI due to stent thrombosis.
- Assessed major adverse cardiac events over a 1-year follow-up period.
Main Results:
- Stent thrombosis patients had significantly higher rates of cardiogenic shock (21.3% vs 4.8%).
- Repeat revascularization rates were substantially higher in the stent thrombosis group (35.7% vs 9.1%).
- Major cardiovascular event rates were significantly elevated in stent thrombosis patients (57.1% vs 31.2%).
Conclusions:
- Long-term clinical outcomes for patients with stent thrombosis are unfavorable.
- Higher rates of adverse events necessitate improved therapeutic strategies for stent thrombosis.
Related Concept Videos
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:30Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
01:19Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
01:27Peripheral Artery Disease III: Interprofessional Care
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...